Interestingly, patient-specific enhancers have previously been identified at the CD69 gene in cases of mixed-phenotype acute leukemia.39 Taken together, our data confirm that the differential enhancer regions identified at MEIS1, RUNX2, and CD69 are indeed enhancers for these genes. Here, RUNX2 is linked to acute leukemia.